Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

Completed · Phase 2

Conditions studied: Crohn's Disease

In brief

The purpose is to determine whether RPC1063 is effective in the treatment of Crohn's disease.

Key facts

Study ID
NCT02531113
Run by
Celgene
People needed
69
Starts
2015-10-09
Expected to finish
2019-11-28
Last updated by the study team
2021-01-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.